Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2013 Oct 15;12(12):2827–2836. doi: 10.1158/1535-7163.MCT-13-0383

Figure 6.

Figure 6

Three-day biodistribution of I125-labeled chTNT-3 administered 1 d after chemotherapy treatment of MAD109-bearing mice with and without chTNT-3/IL-2 pretreatment. (A) Vinblastine (1.4 mg/kg) treatment and (B) VP-16 (30 mg/kg) treatment in MAD109 bearing BALB/c mice. Error bars represent standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001 as determine using one-way ANOVA followed by Tukey's post-hoc test. N = 4 mice for all groups.